164 related articles for article (PubMed ID: 18830565)
1. Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor.
Ogura K; Shiga T; Yokochi M; Yuzawa S; Burke TR; Inagaki F
J Biomol NMR; 2008 Nov; 42(3):197-207. PubMed ID: 18830565
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain.
Phan J; Shi ZD; Burke TR; Waugh DS
J Mol Biol; 2005 Oct; 353(1):104-15. PubMed ID: 16165154
[TBL] [Abstract][Full Text] [Related]
3. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain.
Thornton KH; Mueller WT; McConnell P; Zhu G; Saltiel AR; Thanabal V
Biochemistry; 1996 Sep; 35(36):11852-64. PubMed ID: 8794768
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
5. Structural and biophysical investigation of the interaction of a mutant Grb2 SH2 domain (W121G) with its cognate phosphopeptide.
Papaioannou D; Geibel S; Kunze MB; Kay CW; Waksman G
Protein Sci; 2016 Mar; 25(3):627-37. PubMed ID: 26645482
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
7. Determination of binding potency of peptidic inhibitors of Grb2-SH2 by using the protein-captured biosensor method.
Lung FD; Li WC; Chang YH; Chen HM
Protein Pept Lett; 2008; 15(8):808-10. PubMed ID: 18855753
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain.
Xiao T; Sun L; Zhang M; Li Z; Haura EB; Schonbrunn E; Ji H
Bioorg Med Chem Lett; 2021 Nov; 51():128354. PubMed ID: 34506932
[TBL] [Abstract][Full Text] [Related]
11. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
Song YL; Tan J; Luo XM; Long YQ
Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
[TBL] [Abstract][Full Text] [Related]
12. Structural and energetic aspects of Grb2-SH2 domain-swapping.
Benfield AP; Whiddon BB; Clements JH; Martin SF
Arch Biochem Biophys; 2007 Jun; 462(1):47-53. PubMed ID: 17466257
[TBL] [Abstract][Full Text] [Related]
13. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
[TBL] [Abstract][Full Text] [Related]
14. High resolution crystal structure of the Grb2 SH2 domain with a phosphopeptide derived from CD28.
Higo K; Ikura T; Oda M; Morii H; Takahashi J; Abe R; Ito N
PLoS One; 2013; 8(9):e74482. PubMed ID: 24098653
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of the SH2 domain of Grb2/Ash complexed with EGF receptor-derived phosphotyrosine-containing peptide.
Tsuchiya S; Ogura K; Hatanaka H; Nagata K; Terasawa H; Mandiyan V; Schlessinger J; Aimoto S; Ohta H; Inagaki F
J Biochem; 1999 Jun; 125(6):1151-9. PubMed ID: 10348919
[TBL] [Abstract][Full Text] [Related]
16. NMR assignment of free
Sanches K; Caruso ÍP; Almeida FCL; Melo FA
Biomol NMR Assign; 2019 Oct; 13(2):295-298. PubMed ID: 31028611
[TBL] [Abstract][Full Text] [Related]
17. Discovery of thioether-bridged cyclic pentapeptides binding to Grb2-SH2 domain with high affinity.
Jiang S; Liao C; Bindu L; Yin B; Worthy KW; Fisher RJ; Burke TR; Nicklaus MC; Roller PP
Bioorg Med Chem Lett; 2009 May; 19(10):2693-8. PubMed ID: 19362470
[TBL] [Abstract][Full Text] [Related]
18. Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain.
Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
J Biomol NMR; 1997 Oct; 10(3):273-8. PubMed ID: 9390405
[TBL] [Abstract][Full Text] [Related]
19. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the SH3 domain of growth factor receptor-bound protein 2.
Bolgov A; Korban S; Luzik D; Zhemkov V; Kim M; Rogacheva O; Bezprozvanny I
Acta Crystallogr F Struct Biol Commun; 2020 Jun; 76(Pt 6):263-270. PubMed ID: 32510467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
